SAN DIEGO ( TheStreet) -- The number of prescriptions for Arena Pharmaceuticals' (ARNA - Get Report) weight-loss pill Belviq rose either 12% or 16% for the week ended July 12 -- the difference depends on which of the two major drug prescriptions data services (IMS Health or Symphony) you follow.
One Short Seller's Take On Arena's Slow Belviq Launch
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.